First report 41m ago•Last update 41m ago
Germany's BioNTech to close three factories due to low demand for mRNA injections
BioNTech announced the closure of three factories in Germany, citing low capacity utilization and decreased demand for mRNA injections developed to combat COVID-19, reflecting a shift in global healthcare priorities.
Background
The COVID-19 pandemic spurred rapid development and production of mRNA vaccines, with companies like BioNTech becoming key global suppliers. As the pandemic's acute phase recedes, demand for these specific injections has significantly decreased, leading to adjustments in manufacturing capacity worldwide.
Quorum · collective opinions
Germany's BioNTech to close three factories due to low demand
First report 1h agoLast update 1h ago1 takes 1
impact of reduced vaccine demandneutralShow 1 post
started 1h ago•Last update 1h ago
The factory closures highlight the impact of reduced demand for COVID-19 vaccines and the adaptation of production to new market conditions.
iWitness comments
No comments yet — be the first to weigh in.